Literature DB >> 11032852

Oral tolerance, an active immunologic process mediated by multiple mechanisms.

H L Weiner1.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11032852      PMCID: PMC314352          DOI: 10.1172/JCI11348

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  24 in total

1.  Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.

Authors:  A M Thornton; E M Shevach
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin.

Authors:  D Melamed; J Fishman-Lovell; Z Uni; H L Weiner; A Friedman
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

3.  Oral tolerance to ovalbumin in mice: studies of chemically modified and 'biologically filtered' antigen.

Authors:  M G Bruce; A Ferguson
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

Review 4.  Autoimmunity, microbial immunity and the immunological homunculus.

Authors:  I R Cohen; D B Young
Journal:  Immunol Today       Date:  1991-04

5.  Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia.

Authors:  K J Becker; R M McCarron; C Ruetzler; O Laban; E Sternberg; K C Flanders; J M Hallenbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

6.  Anergy and suppression regulate CD4(+) T cell responses to a self peptide.

Authors:  M S Jordan; M P Riley; H von Boehmer; A J Caton
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

7.  T-cell activation and receptor downmodulation precede deletion induced by mucosally administered antigen.

Authors:  J M Benson; K A Campbell; Z Guan; I E Gienapp; S S Stuckman; T Forsthuber; C C Whitacre
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

8.  Peripheral deletion of antigen-reactive T cells in oral tolerance.

Authors:  Y Chen; J Inobe; R Marks; P Gonnella; V K Kuchroo; H L Weiner
Journal:  Nature       Date:  1995-07-13       Impact factor: 49.962

9.  The regulation of immune responses to dietary protein antigens.

Authors:  A M Mowat
Journal:  Immunol Today       Date:  1987

10.  Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.

Authors:  M Asano; M Toda; N Sakaguchi; S Sakaguchi
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

View more
  33 in total

Review 1.  CD40L in autoimmunity and mucosally induced tolerance.

Authors:  Mi-Na Kweon; Hiroshi Kiyono
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 2.  Oral tolerance of food.

Authors:  Steve Stanley
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.806

Review 3.  Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?

Authors:  M Peakman; C M Dayan
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

Review 4.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

Authors:  Reinhard Hohlfeld; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

5.  Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes.

Authors:  J S Petersen; S Bregenholt; V Apostolopolous; D Homann; T Wolfe; A Hughes; K De Jongh; M Wang; T Dyrberg; M G Von Herrath
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

6.  Reply to Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.

Authors:  Hikaru Sugimoto; Valerie S LeBleu; Dattatreyamurty Bosukonda; Peter Keck; Gangadhar Taduri; Wibke Bechtel; Hirokazu Okada; William Carlson; Philippe Bey; Mary Rusckowski; Björn Tampe; Desiree Tampe; Keizo Kanasaki; Michael Zeisberg; Raghu Kalluri
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 7.  M cell-targeted mucosal vaccine strategies.

Authors:  M Yamamoto; D W Pascual; H Kiyono
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

8.  The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen.

Authors:  C Porporatto; M M Canali; I D Bianco; S G Correa
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

9.  Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Biologics       Date:  2007-03

Review 10.  Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new?

Authors:  Yvonne Vercoulen; Nienke H van Teijlingen; Ismé M de Kleer; Sylvia Kamphuis; Salvatore Albani; Berent J Prakken
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.